(16322749), M. A. Y., (16555786), M. O. A. R., (16515247), A. A. H., (16555788), A. R. P., (16555791), M. T. A., (16515249), R. M. H., . . . (16328993), A. J. N. (2020). Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis.
Chicago Style (17th ed.) Citation(16322749), Mohamed A. Yassin, et al. Denosumab Versus Zoledronic Acid for Patients with Beta-thalassemia Major-induced Osteoporosis. 2020.
MLA (9th ed.) Citation(16322749), Mohamed A. Yassin, et al. Denosumab Versus Zoledronic Acid for Patients with Beta-thalassemia Major-induced Osteoporosis. 2020.
Warning: These citations may not always be 100% accurate.